diabetes management, and BMI at baseline(Table 1). The demographics for subjects in thistrial were representative of a type 2 diabetespopulation with obesity (as indicated by arange of mean BMI of 32.5–36.3 kg/m 2, Table 1) and suboptimal glycemic control (range ofmean HbA 1c7.4–7.7% at baseline). At baseline,EXENATIDE DOSE-RANGING STUDY 4695678_05_p467-477  5/18/05  12:44 PM  Page 469